Caio Júlio César Dos Santos Fernandes

This study looks at how well the oral medication selexipag works over the long term for people with a specific type of lung disease called schistosomiasis-associated pulmonary arterial hypertension. Researchers will compare patients who took selexipag with similar patients who di…

This study reviews medical records of 15 adults with pulmonary arterial hypertension (PAH) who switched from one medication to riociguat while on triple therapy. The goal is to see if the switch improves walking distance, symptoms, and blood markers at 6 months. No new treatments…